This came after Sun Pharma presented the BE study report along with revised clinical trial (CT) protocol no. ICR/23/013 ver.

It’s empowering to know you can change your fate when it comes to your health. Committing to a low-glycemic breakfast is the ...

In this video, Mikhail Varshavski, DO, who goes by "Dr. Mike" on YouTube, takes a look at the best artificial intelligence ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Dr. Graham Simpson, MD, who is board-certified in internal medicine, anti-aging medicine and emergency medicine, and is the ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...

New research at Lund University shows that the biological parents' genes affect the child's insulin function and capacity to ...

Intermittent fasting shows promise in enhancing cognitive function and supporting brain health, with implications for ...